Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call

Go back to Leerink Partners Raises Price Target on Cardinal Health (CAH) Following Conference Call

UBS Raises Price target on Cardinal Health (CAH) Following 1Q16 Conference Call

November 3, 2015 8:36 AM EST

UBS reiterated a Buy rating on Cardinal Health (NYSE: CAH), and raise the price target to $100.00 (from $97.00), following 1Q16 earnings call. On CAH's F1Q16 earnings call, the company provided some fresh input on the outlook for both brand and generic pricing. Regarding brand drug inflation, the rate in F1Q16 was slightly higher than the prior... More

Pre-Open Stock Movers 11/02: (HTCH) (DYAX) (CTCT) Higher; (CMG) (CL) (V) Lower (more...)

November 2, 2015 9:28 AM EST

Hutchinson Technology (Nasdaq: HTCH) 104% HIGHER; TDK Corporation and Hutchinson Technology Incorporated (Nasdaq: HTCH) jointly announced that they have entered into a definitive merger agreement under which TDK will acquire all of the outstanding shares of common stock of HTI for base consideration of US$3.62 per share, plus additional consideration of up to US$0.38 per share, depending on the level of cash (subject to certain adjustments) less any outstanding borrowings on HTI's revolving line of credit ("net cash") held by HTI as of... More

Cardinal Health (CAH) Tops Q1 EPS by 28c

November 2, 2015 7:47 AM EST

Cardinal Health (NYSE: CAH) reported Q1 EPS of $1.38, $0.28 better than the analyst estimate of $1.10. Revenue for the quarter came in at $28.1 billion versus the consensus estimate of $27.18 billion.

For earnings history and earnings-related data on Cardinal Health (CAH) click here.

... More